Sector intelligence and perspective

Pluristem (PSTI) and Indiana University evaluating PLX-R18 in Acute Radiation Syndrome (ARS)

April 23, 2018

PSTI closed Friday at $1.20 (-$0.04) and is UP +$0.04 in the pre-market The 5-year joint project was granted $2.5 million from the U.S. NIH

Organovo (ONVO) Achieves liver disease and intestinal 3D bio-printed tissue models milestones - BUY

April 16, 2018

Closed down -$0.04 and is up +$0.0 or +7.28% to $1.09 ONVO continues to map out a range of relevant conditions for creating NASH, including all components of the disease (fat accumulation, inflammation and fibrosis).

Organovo Holdings (ONVO) presents data on creating drug profile of chronic liver disease progression - BUY

April 12, 2018

ONVO closed down -$0.01 to $1.01 and is UP +$0.04 or +$0.04 or +3.96 These new data points provide strong support for the application of the NAFLD model to high-value drug profiling, including the possible creation of patient or population-specific model variants.

Roll Call

The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.